MYL12A

Myosin regulatory light chain 12A · P19105 · MYL12A on Sugi Atlas →

0 patent compounds predicted against MYL12A, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MYL12A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure PHASE2COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
Transcutaneous Functional Magnetic Muscle Stimulation in Critically Ill nanUNKNOWN
Genetic Analysis of African-Americans With High Blood Pressure nanCOMPLETED
Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium nanCOMPLETED
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome nanCOMPLETED
Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia nanCOMPLETED
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China nanENROLLING_BY_INVITATION
Congenital Muscle Disease Study of Patient and Family Reported Medical Information nanRECRUITING
Evaluating Changes in Skeletal Muscle Proteins Following Resistance Exercise and Single-Leg Disuse nanCOMPLETED
Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies nanRECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Chronic Muscle Disuse in the Elderly nanCOMPLETED
Characteristics of Nondystrophic Myotonias nanCOMPLETED
3D-Microscopic Muscle Architecture in Cerebral Palsy nanRECRUITING
Molecular and Genetic Studies of Congenital Myopathies nanRECRUITING
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Regulation of Muscle Protein Phenotype in Humans With Obesity nanCOMPLETED
MYT1L Syndrome: a Rare Paediatric Genetic Syndrome Responsible for a Neurodevelopmental Disorder nanRECRUITING
Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS) nanRECRUITING
Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure nanUNKNOWN
The Muscle in Cerebral Palsy; Sarcomere Length in Vivo and Microscopic Characterization of Biopsies. nanRECRUITING
Pediatric Cardiomyopathy Mutation Analysis nanRECRUITING
Imaging Genetics of Laryngeal Dystonia nanRECRUITING
Natural History Study for Patients With Nemaline Myopathy in Belgium nanNOT_YET_RECRUITING
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease nanCOMPLETED
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy nanUNKNOWN
Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy nanUNKNOWN
Role of Ultrasound in Diagnosis of Muscle Diseases nanCOMPLETED
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MYL12A binder may also engage these)

ProteinNameSimilarity
Q3THE2 1.000 Q3THE2 →
P13832 1.000 P13832 →
Q5RC34 1.000 Q5RC34 →
A4IF97 1.000 A4IF97 →
P24032 1.000 P24032 →
Q5RBA4 1.000 Q5RBA4 →
P29269 1.000 P29269 →
P18666 1.000 P18666 →
P24844 1.000 P24844 →
Q9CQ19 1.000 Q9CQ19 →
P02612 1.000 P02612 →
O14950 1.000 O14950 →
Q5E9E2 1.000 Q5E9E2 →
P05944 1.000 P05944 →
Q09510 1.000 Q09510 →
Q64122 1.000 Q64122 →
P40423 0.999 P40423 →
P05963 0.999 P05963 →
B7SNI3 0.999 B7SNI3 →
P02608 0.998 P02608 →
P24732 0.997 P24732 →
P97457 0.997 P97457 →
O93409 0.997 O93409 →
P13543 0.997 P13543 →
P02611 0.997 P02611 →
Q96A32 0.997 Q96A32 →
Q01449 0.996 Q01449 →
F1SSF9 0.996 F1SSF9 →
P07461 0.996 P07461 →
P10916 0.995 P10916 →